Metropolitan Life Insurance Company (MetLife)’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-70,020
Closed -$7.96M 22
2024
Q1
$7.96M Sell
70,020
-616
-0.9% -$70.6K 0.35% 47
2023
Q4
$7.77M Sell
70,636
-1,163
-2% -$116K 0.37% 45
2023
Q3
$6.95M Sell
71,799
-3,983
-5% -$418K 0.36% 44
2023
Q2
$8.26M Sell
75,782
-2,204
-3% -$235K 0.4% 43
2023
Q1
$7.9M Sell
77,986
-20,732
-21% -$2.19M 0.41% 42
2022
Q4
$10.8M Sell
98,718
-3,579
-3% -$371K 0.48% 37
2022
Q3
$9.9M Sell
102,297
-1,211
-1% -$129K 0.47% 36
2022
Q2
$11.2M Sell
103,508
-3,649
-3% -$414K 0.49% 34
2022
Q1
$12.7M Sell
107,157
-132,928
-55% -$16.5M 0.45% 41
2021
Q4
$33.8M Sell
240,085
-6,472
-3% -$828K 0.46% 30
2021
Q3
$29.1M Sell
246,557
-8,674
-3% -$1.07M 0.42% 37
2021
Q2
$29.6M Buy
255,231
+4,954
+2% +$578K 0.42% 35
2021
Q1
$30M Sell
250,277
-13,546
-5% -$1.6M 0.45% 34
2020
Q4
$28.9M Sell
263,823
-12,081
-4% -$1.31M 0.43% 39
2020
Q3
$30M Sell
275,904
-11,608
-4% -$1.18M 0.51% 27
2020
Q2
$26.3M Sell
287,512
-10,168
-3% -$919K 0.47% 36
2020
Q1
$23.5M Sell
297,680
-2,672
-0.9% -$223K 0.48% 35
2019
Q4
$26.1M Buy
300,352
+1,680
+0.6% +$141K 0.42% 40
2019
Q3
$25M Buy
298,672
+38,446
+15% +$3.27M 0.42% 38
2019
Q2
$21.9M Buy
260,226
+21,640
+9% +$1.7M 0.37% 47
2019
Q1
$19.1M Sell
238,586
-10,652
-4% -$793K 0.35% 56
2018
Q4
$18M Sell
249,238
-573
-0.2% -$40.3K 0.36% 50
2018
Q3
$18.3M Sell
249,811
-9,375
-4% -$616K 0.31% 61
2018
Q2
$15.8M Sell
259,186
-5,737
-2% -$348K 0.26% 71
2018
Q1
$15.9M Buy
264,923
+1,609
+0.6% +$96.9K 0.22% 67
2017
Q4
$15M Sell
263,314
-560,370
-68% -$31.1M 0.2% 75
2017
Q3
$44M Sell
823,684
-16,600
-2% -$833K 0.28% 60
2017
Q2
$40.8M Sell
840,284
-26,229
-3% -$1.19M 0.28% 60
2017
Q1
$38.5M Buy
866,513
+122,244
+16% +$5.28M 0.27% 69
2016
Q4
$28.6M Sell
744,269
-13,609
-2% -$540K 0.21% 91
2016
Q3
$32.1M Sell
757,878
-5,001
-0.7% -$214K 0.23% 79
2016
Q2
$30M Sell
762,879
-10,230
-1% -$407K 0.22% 81
2016
Q1
$32.3M Sell
773,109
-23,561
-3% -$933K 0.25% 76
2015
Q4
$35.8M Sell
796,670
-13,575
-2% -$599K 0.27% 70
2015
Q3
$32.6M Sell
810,245
-13,952
-2% -$658K 0.23% 80
2015
Q2
$40.5M Sell
824,197
-14,788
-2% -$710K 0.28% 66
2015
Q1
$38.9M Sell
838,985
-9,336
-1% -$429K 0.29% 68
2014
Q4
$38.2M Sell
848,321
-13,981
-2% -$609K 0.26% 73
2014
Q3
$35.9M Sell
862,302
-11,473
-1% -$485K 0.26% 77
2014
Q2
$35.7M Sell
873,775
-68,390
-7% -$2.69M 0.25% 81
2014
Q1
$36.3M Sell
942,165
-16,269
-2% -$627K 0.25% 79
2013
Q4
$36.7M Sell
958,434
-9,504
-1% -$350K 0.26% 79
2013
Q3
$32.1M Sell
967,938
-7,975
-0.8% -$280K 0.25% 81
2013
Q2
$34M Buy
+975,913
New +$35.8M 0.27% 67

Other funds holding ABT

Metropolitan Life Insurance Company (MetLife)'s ABT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Abbott (ABT) in Q2 2024, closing a stake of 70,020 shares — an estimated $7.96M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ABT in Q2 2013 and held it in 44 quarters. The position peaked at $44M in Q3 2017. 2,864 funds tracked by Wall St. Rank hold ABT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Abbott position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 70,020 Abbott shares in Q2 2024, an estimated $7.96M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Abbott in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Abbott position peaked at $44M in Q3 2017.
  • 2,864 funds tracked by Wall St. Rank held Abbott as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.